drugset / Trial / NCT01969019

A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy

NCT01969019 ↗

Phase 4 Unknown 70 enrolled Ruijin Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This study was designed to compare the efficacy and safety of 4.5g iv MP administered in 12 weeks and 4 weeks.

Timeline

Start
2010-01
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylprednisolone Other / unclassified 0.25 g Intravenous
Comparator Prednisone Other / unclassified — Oral